Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Beutels

Showing results (101-110 of 254) with videos related to

Pageof 26
Sort By:
BMC Infectious Diseases|January 22, 2009
Mining social mixing patterns for infectious disease models based on a two-day population survey in BelgiumNiel Hens, Nele Goeyvaerts, Marc Aerts, et al.
Vaccine|October 4, 2011
Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?Joke Bilcke, Benson Ogunjimi, Frank Hulstaert, et al.
Journal of Virology|October 31, 2014
Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgiaPieter Meysman, Benson Ogunjimi, Stefan Naulaerts, et al.
The Lancet Regional Health. Europe|October 13, 2021
Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemicMark Jit, Aparna Ananthakrishnan, Martin McKee, et al.
Statistics in Medicine|February 25, 2012
Estimating vaccination coverage for the trivalent measles-mumps-rubella vaccine from trivariate serological dataNele Goeyvaerts, Niel Hens, Heidi Theeten, et al.
Mathematical Biosciences|January 29, 2009
Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicellaBenson Ogunjimi, Niel Hens, Nele Goeyvaerts, et al.
Pharmacoeconomics|September 13, 2005
The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccineRobert Welte, Caroline L Trotter, W John Edmunds, et al.
Pharmacoeconomics|February 26, 2016
Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and ChallengesSevan Dirmesropian, James G Wood, C Raina MacIntyre, et al.
The Lancet. Infectious Diseases|September 5, 2020
Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysisJulie Schenk, Steven Abrams, Heidi Theeten, et al.
BMC Research Notes|June 18, 2020
SOCRATES: an online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19Lander Willem, Thang Van Hoang, Sebastian Funk, et al.
Pageof 26

Showing results (101-110 of 254) with videos related to

Sort By:
Pageof 26
BMC Infectious Diseases|January 22, 2009
Mining social mixing patterns for infectious disease models based on a two-day population survey in BelgiumNiel Hens, Nele Goeyvaerts, Marc Aerts, et al.
Vaccine|October 4, 2011
Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?Joke Bilcke, Benson Ogunjimi, Frank Hulstaert, et al.
Journal of Virology|October 31, 2014
Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgiaPieter Meysman, Benson Ogunjimi, Stefan Naulaerts, et al.
The Lancet Regional Health. Europe|October 13, 2021
Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemicMark Jit, Aparna Ananthakrishnan, Martin McKee, et al.
Statistics in Medicine|February 25, 2012
Estimating vaccination coverage for the trivalent measles-mumps-rubella vaccine from trivariate serological dataNele Goeyvaerts, Niel Hens, Heidi Theeten, et al.
Mathematical Biosciences|January 29, 2009
Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicellaBenson Ogunjimi, Niel Hens, Nele Goeyvaerts, et al.
Pharmacoeconomics|September 13, 2005
The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccineRobert Welte, Caroline L Trotter, W John Edmunds, et al.
Pharmacoeconomics|February 26, 2016
Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and ChallengesSevan Dirmesropian, James G Wood, C Raina MacIntyre, et al.
The Lancet. Infectious Diseases|September 5, 2020
Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysisJulie Schenk, Steven Abrams, Heidi Theeten, et al.
BMC Research Notes|June 18, 2020
SOCRATES: an online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19Lander Willem, Thang Van Hoang, Sebastian Funk, et al.
Pageof 26